USFDA conducted an un-announced audit of Jeevan Scientific Technology Ltd's Bioanalytical facility in Hyderabad. The purpose of this audit was to review the BA/BE studies conducted at our facilities. The auditors started the review on 20th January, 2020 and completed on 24th January, 2020.
The audit concluded with 'No Observations' and Auditors are pleased with our procedures.
This Audit is specifically to access and approve the Bioequivalence studies conducted by JSTL for Pharmaceutical companies across the globe.
Shares of Jeevan Scientific Technology Ltd was last trading in BSE at Rs.18.95 as compared to the previous close of Rs. 18.4. The total number of shares traded during the day was 121 in over 9 trades.
The stock hit an intraday high of Rs. 18.95 and intraday low of 18. The net turnover during the day was Rs. 2288.